| | Increased Mortality Seen With HbA1c Below 7.5%
Major Finding: HbA1c values below 7.5% were associated with increased all-cause mortality and cardiovascular events.
Data Source: A general practice database analysis of 47,970 type 2 diabetes patients with recently intensified glucose-lowering therapy.
Disclosures: Funding by Eli Lilly & Co. The investigators disclosed ties to numerous manufacturers of diabetes treatments, including Eli Lilly.
PII: S1558-0164(10)70060-2 doi:10.1016/S1558-0164(10)70060-2 © 2010 Elsevier Inc. All rights reserved. | |
|
|